PYXS Pyxis Oncology, Inc.
Healthcare$1.96+1.03%ClosedMarket Cap: $124.2M
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$5.50
Target (Median)
$5.50
Target Range
$5.00 - $6.00
Upside from current price: 180.6%
Rating Distribution
1 Strong Buy8 Buy1 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-03-24 | Stifel | maintain | Buy | Buy |
| 2026-03-24 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-12-19 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-12-19 | RBC Capital | maintain | Outperform | Outperform |
| 2025-11-24 | Stephens & Co. | maintain | Overweight | Overweight |
| 2025-11-04 | Guggenheim | maintain | Buy | Buy |
| 2025-08-19 | HC Wainwright & Co. | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-1.25 | $3.6M | 7 |
| Sun Dec 31 | $-1.25 | $13.8M | 7 |
| Mon Dec 31 | $-0.96 | $46.4M | 2 |
| Tue Dec 31 | $-0.58 | $115.2M | 5 |